Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Colitis-induced bone loss is gender dependent and associated with increased inflammation.

Irwin R, Lee T, Young VB, Parameswaran N, McCabe LR.

Inflamm Bowel Dis. 2013 Jul;19(8):1586-97. doi: 10.1097/MIB.0b013e318289e17b.

2.

Strain-specific colitis susceptibility in IL10-deficient mice depends on complex gut microbiota-host interactions.

Büchler G, Wos-Oxley ML, Smoczek A, Zschemisch NH, Neumann D, Pieper DH, Hedrich HJ, Bleich A.

Inflamm Bowel Dis. 2012 May;18(5):943-54. doi: 10.1002/ibd.21895. Epub 2012 Jan 11.

PMID:
22238116
3.

Intestinal microbiota composition of interleukin-10 deficient C57BL/6J mice and susceptibility to Helicobacter hepaticus-induced colitis.

Yang I, Eibach D, Kops F, Brenneke B, Woltemate S, Schulze J, Bleich A, Gruber AD, Muthupalani S, Fox JG, Josenhans C, Suerbaum S.

PLoS One. 2013 Aug 9;8(8):e70783. doi: 10.1371/journal.pone.0070783. eCollection 2013.

4.

Helicobacter bilis infection accelerates and H. hepaticus infection delays the development of colitis in multiple drug resistance-deficient (mdr1a-/-) mice.

Maggio-Price L, Shows D, Waggie K, Burich A, Zeng W, Escobar S, Morrissey P, Viney JL.

Am J Pathol. 2002 Feb;160(2):739-51.

5.

Dual infection with Helicobacter bilis and Helicobacter hepaticus in p-glycoprotein-deficient mdr1a-/- mice results in colitis that progresses to dysplasia.

Maggio-Price L, Bielefeldt-Ohmann H, Treuting P, Iritani BM, Zeng W, Nicks A, Tsang M, Shows D, Morrissey P, Viney JL.

Am J Pathol. 2005 Jun;166(6):1793-806.

6.

Helicobacter hepaticus promotes azoxymethane-initiated colon tumorigenesis in BALB/c-IL10-deficient mice.

Nagamine CM, Rogers AB, Fox JG, Schauer DB.

Int J Cancer. 2008 Feb 15;122(4):832-8.

7.

Lactobacillus reuteri promotes Helicobacter hepaticus-associated typhlocolitis in gnotobiotic B6.129P2-IL-10(tm1Cgn) (IL-10(-/-) ) mice.

Whary MT, Taylor NS, Feng Y, Ge Z, Muthupalani S, Versalovic J, Fox JG.

Immunology. 2011 Jun;133(2):165-78. doi: 10.1111/j.1365-2567.2011.03423.x. Epub 2011 Mar 23.

8.
9.

Modulation of host immune responses by the cytolethal distending toxin of Helicobacter hepaticus.

Pratt JS, Sachen KL, Wood HD, Eaton KA, Young VB.

Infect Immun. 2006 Aug;74(8):4496-504.

10.

Helicobacter hepaticus-induced colitis in interleukin-10-deficient mice: cytokine requirements for the induction and maintenance of intestinal inflammation.

Kullberg MC, Rothfuchs AG, Jankovic D, Caspar P, Wynn TA, Gorelick PL, Cheever AW, Sher A.

Infect Immun. 2001 Jul;69(7):4232-41.

11.

Pathogenesis of mouse hepatitis virus infection in gamma interferon-deficient mice is modulated by co-infection with Helicobacter hepaticus.

Compton SR, Ball-Goodrich LJ, Zeiss CJ, Johnson LK, Johnson EA, Macy JD.

Comp Med. 2003 Apr;53(2):197-206.

PMID:
12784855
12.

Helicobacter hepaticus HHGI1 is a pathogenicity island associated with typhlocolitis in B6.129-IL10 tm1Cgn mice.

Ge Z, Sterzenbach T, Whary MT, Rickman BH, Rogers AB, Shen Z, Taylor NS, Schauer DB, Josenhans C, Suerbaum S, Fox JG.

Microbes Infect. 2008 Jun;10(7):726-33. doi: 10.1016/j.micinf.2008.03.011. Epub 2008 Apr 4.

13.

Helicobacter hepaticus triggers colitis in specific-pathogen-free interleukin-10 (IL-10)-deficient mice through an IL-12- and gamma interferon-dependent mechanism.

Kullberg MC, Ward JM, Gorelick PL, Caspar P, Hieny S, Cheever A, Jankovic D, Sher A.

Infect Immun. 1998 Nov;66(11):5157-66.

14.

Probiotic Lactobacillus spp. diminish Helicobacter hepaticus-induced inflammatory bowel disease in interleukin-10-deficient mice.

Peña JA, Rogers AB, Ge Z, Ng V, Li SY, Fox JG, Versalovic J.

Infect Immun. 2005 Feb;73(2):912-20.

15.

Sex influence on chronic intestinal inflammation in Helicobacter hepaticus-infected A/JCr mice.

Livingston RS, Myles MH, Livingston BA, Criley JM, Franklin CL.

Comp Med. 2004 Jun;54(3):301-8.

PMID:
15253277
16.

Helicobacter hepaticus urease is not required for intestinal colonization but promotes hepatic inflammation in male A/JCr mice.

Ge Z, Lee A, Whary MT, Rogers AB, Maurer KJ, Taylor NS, Schauer DB, Fox JG.

Microb Pathog. 2008 Jul;45(1):18-24. doi: 10.1016/j.micpath.2008.02.003. Epub 2008 Mar 27.

17.

Hcp and VgrG1 are secreted components of the Helicobacter hepaticus type VI secretion system and VgrG1 increases the bacterial colitogenic potential.

Bartonickova L, Sterzenbach T, Nell S, Kops F, Schulze J, Venzke A, Brenneke B, Bader S, Gruber AD, Suerbaum S, Josenhans C.

Cell Microbiol. 2013 Jun;15(6):992-1011. doi: 10.1111/cmi.12094. Epub 2013 Jan 17.

PMID:
23278999
18.

Helicobacter hepaticus infection in mice: models for understanding lower bowel inflammation and cancer.

Fox JG, Ge Z, Whary MT, Erdman SE, Horwitz BH.

Mucosal Immunol. 2011 Jan;4(1):22-30. doi: 10.1038/mi.2010.61. Epub 2010 Oct 13. Review.

19.

Cytolethal distending toxin is essential for Helicobacter hepaticus colonization in outbred Swiss Webster mice.

Ge Z, Feng Y, Whary MT, Nambiar PR, Xu S, Ng V, Taylor NS, Fox JG.

Infect Immun. 2005 Jun;73(6):3559-67.

20.

Coinfection with Enterohepatic Helicobacter species can ameliorate or promote Helicobacter pylori-induced gastric pathology in C57BL/6 mice.

Ge Z, Feng Y, Muthupalani S, Eurell LL, Taylor NS, Whary MT, Fox JG.

Infect Immun. 2011 Oct;79(10):3861-71. doi: 10.1128/IAI.05357-11. Epub 2011 Jul 25.

Supplemental Content

Support Center